What requirement must the inpatient pharmacy fulfill before dispensing Fentora to Mr. Wood?

The requirement for the inpatient pharmacy to enroll in the TIRF (Transmucosal Immediate Release Fentanyl) program before dispensing Fentora is essential because Fentora contains fentanyl, a potent opioid used for managing breakthrough pain in cancer patients. The TIRF program is specifically designed to ensure the safe use of transmucosal fentanyl products. It mandates that healthcare providers and pharmacies who prescribe or dispense these medications must be properly educated about the risks associated with opioids and the specific requirements for prescribing and dispensing these drugs.

Enrollment in the TIRF program involves training and acquiring the necessary knowledge to handle these medications responsibly, thus minimizing the potential for misuse or accidental overdose. This aspect of patient safety is critical given the serious risks associated with potent opioids and the specific regulations surrounding their distribution. Therefore, fulfilling this requirement is necessary for the inpatient pharmacy to dispense Fentora to Mr. Wood safely and legally.